DRUG · Mapped RxNorm record
gemcitabine hydrochloride
Normalized identity: gemcitabine hydrochlorideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
NCT00054197
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
paclitaxel poliglumex
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
vinorelbine tartrate
Normalized identity: vinorelbine tartrateView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedPolyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
gemcitabine hydrochlorideDRUG · verified · RxNorm: gemcitabine hydrochloride
vinorelbine tartrateDRUG · verified · RxNorm: vinorelbine tartrate
Sponsors & collaborators
CTI BioPharmalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00054197 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.